Key Market Indicators
Austrian Antiinfective Medicine Sales are projected to reach $307 million by 2028, up from $302 million in 2023. This represents a modest annual growth rate of 0.2%. The market has seen a gradual rise of 0.6% per year since 2015. In 2023, Austria was ranked ninth in the global market, with Finland taking the lead at $302 million. Spain, Croatia, and Australia followed closely, securing the second, third, and fourth spots, respectively. In a dramatic downturn, Austrian Antibiotics Exports plummeted to just $231,000 in 2018, a staggering 99.9% decline from the $201 million recorded in 2017. This steep fall continues a trend observed since 2008, during which time the country's antibiotic supply has decreased by 74.8% annually. Similarly, Austrian Antibiotics Imports saw a significant drop, falling to $490,000 in 2018 from $278 million the previous year. This marks a 99.8% decrease compared to 2017. Since 1999, Austrian demand for imported antibiotics has steadily declined by 72.5% year on year.
